Catalog Number TVTS4 |
Device Problem
Migration or Expulsion of Device (1395)
|
Patient Problems
Erosion (1750); Unspecified Infection (1930); Neurological Deficit/Dysfunction (1982); Pain (1994); Scar Tissue (2060); Blood Loss (2597); No Code Available (3191)
|
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Total number of events ¿ (b)(4).Gynecare tvt secur system - (b)(4).Conclusion: to date, the device has not been returned.If the product is returned for evaluation, any further information derived from the evaluation will be submitted in a supplemental 3500a form.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.
|
|
Event Description
|
It was reported that a patient underwent a gynecological procedure on(b)(6) 2009 and a sling was implanted.The patient experienced pain, erosion of internal bodily tissue and other injuries following the procedure.The patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
It was reported that the patient concurrently underwent cystoscopy.
|
|
Manufacturer Narrative
|
Date sent to the fda: 06/21/2016.(b)(4).Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(6) 2015 through (b)(6) 2015.Supplemental 06.
|
|
Manufacturer Narrative
|
Date sent to the fda: 02/23/2017.(b)(4).Reporting period october 1, 2015 through november 30, 2015.Supplemental 07.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period (b)(4) 2015.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2015 through (b)(6) 2015 supplemental 12 - attachment: [(b)(6) 2015 pah supplemental 12.Xlsx].
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037
reporting period (b)(4) 2015 through (b)(4) 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2015 through november 30, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2015 through november 30, 2015.
|
|
Search Alerts/Recalls
|